Quoin Pharmaceuticals, Ltd. (QNRX) Tops Q4 EPS by 10c

Quoin Pharmaceuticals, Ltd. (NASDAQ: QNRX) reported Q4 EPS of ($0.41), $0.10 better than the analyst estimate of ($0.51).

For earnings history and earnings-related data on Quoin Pharmaceuticals, Ltd. (QNRX) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• XP Inc. (XP) Tops Q2 EPS by 8c
• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown